{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T04:37:44Z","timestamp":1787891864619,"version":"build-2784847793"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fundamental Research Grant Scheme","award":["203\/CIPPM\/6711380"],"award-info":[{"award-number":["203\/CIPPM\/6711380"]}]},{"name":"Higher Institution Centre of Excellence","award":["311\/CIPPM\/4401005"],"award-info":[{"award-number":["311\/CIPPM\/4401005"]}]},{"DOI":"10.13039\/100010449","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.molimm.2019.10.023","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T05:33:52Z","timestamp":1573796032000},"page":"54-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC)"],"prefix":"10.1016","volume":"117","author":[{"given":"Min Han","family":"Lew","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Nor","family":"Norazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee Jun","family":"Tye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2019.10.023_bib0005","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7150\/ijbs.13881","article-title":"Interleukin-10 family and tuberculosis: an Old story renewed","volume":"12","author":"Abdalla","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.molimm.2019.10.023_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190989","article-title":"IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals","volume":"13","author":"Abebe","year":"2018","journal-title":"PloS one"},{"key":"10.1016\/j.molimm.2019.10.023_bib0015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fimmu.2017.00624","article-title":"Diametric role of the latency-associated protein Acr1 of Mycobacterium tuberculosis in modulating the functionality of pre- and Post-maturational stages of dendritic cells","volume":"8","author":"Amir","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0020","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1377\/hlthaff.2011.0303","article-title":"The challenges of developing new tuberculosis vaccines","volume":"30","author":"Barker","year":"2011","journal-title":"Health affairs (Project Hope)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/bip.20153","article-title":"In vitro T-cell immunogenicity of oligopeptides derived from the region 92-110 of the 16-kDa protein of Mycobacterium tuberculosis","volume":"76","author":"Bosze","year":"2004","journal-title":"Biopolymers"},{"key":"10.1016\/j.molimm.2019.10.023_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tube.2004.09.001","article-title":"The tuberculosis vaccine challenge","volume":"85","author":"Brennan","year":"2005","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/sji.12175","article-title":"On the mechanism determining the TH1\/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases","volume":"79","author":"Bretscher","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/745483","article-title":"Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis","volume":"2012","author":"Cavalcanti","year":"2012","journal-title":"Pulmonary medicine"},{"key":"10.1016\/j.molimm.2019.10.023_bib0045","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/imm.12372","article-title":"Comparative study of IgA VH 3 gene usage in healthy TST(-) and TST(+) population exposed to tuberculosis: deep sequencing analysis","volume":"144","author":"Chin","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2019.10.023_bib0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijid.2014.11.026","article-title":"Tuberculosis vaccines--state of the art, and novel approaches to vaccine development","volume":"32","author":"da Costa","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.10.023_bib0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1128\/CVI.13.2.179-186.2006","article-title":"Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis","volume":"13","author":"Demissie","year":"2006","journal-title":"CVI"},{"key":"10.1016\/j.molimm.2019.10.023_bib0060","first-page":"4","article-title":"Cytokines and chemokines in Mycobacterium tuberculosis infection","author":"Domingo-Gonzalez","year":"2016","journal-title":"Microbiol. Spect."},{"key":"10.1016\/j.molimm.2019.10.023_bib0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11673-009-9153-6","article-title":"A New vaccine for tuberculosis: the challenges of development and deployment","volume":"6","author":"Fletcher","year":"2009","journal-title":"J. Bioethic. Inq."},{"key":"10.1016\/j.molimm.2019.10.023_bib0070","doi-asserted-by":"crossref","first-page":"E5636","DOI":"10.1073\/pnas.1611987113","article-title":"CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection","volume":"113","author":"Foreman","year":"2016","journal-title":"PNAS"},{"key":"10.1016\/j.molimm.2019.10.023_bib0075","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.tube.2008.05.002","article-title":"Role of M. Tuberculosis RD-1 region encoded secretory proteins in protective response and virulence","volume":"88","author":"Ganguly","year":"2008","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0080","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1128\/IAI.01990-06","article-title":"T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination","volume":"75","author":"Geluk","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2019.10.023_bib0085","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.tube.2014.05.001","article-title":"Memory T cell subsets in tuberculosis: what should we be targeting?","volume":"94","author":"Henao-Tamayo","year":"2014","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0090","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.vaccine.2018.04.054","article-title":"A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine","volume":"36","author":"Hjertner","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.10.023_bib0095","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tube.2016.08.001","article-title":"Antibodies and tuberculosis","volume":"101","author":"Jacobs","year":"2016","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1159\/000492887","article-title":"Small heat shock Protein16.3 of Mycobacterium tuberculosis: after Two decades of functional characterization","volume":"49","author":"Jee","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.molimm.2019.10.023_bib0110","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/403623","article-title":"Tuberculosis: new aspects of an old disease","volume":"2011","author":"Jordao","year":"2011","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0115","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.1101377","article-title":"IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung","volume":"187","author":"Khader","year":"2011","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2174\/187152607781001817","article-title":"Challenges associated with current and future TB treatment","volume":"7","author":"Laurenzi","year":"2007","journal-title":"Infectious disorders drug targets"},{"key":"10.1016\/j.molimm.2019.10.023_bib0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00253-015-6953-y","article-title":"Expression of a codon-optimised recombinant Ara h 2.02 peanut allergen in Escherichia coli","volume":"100","author":"Lew","year":"2016","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0130","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1073\/pnas.1611776114","article-title":"Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2019.10.023_bib0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4049\/jimmunol.0903856","article-title":"Understanding latent tuberculosis: a moving target","volume":"185","author":"Lin","year":"2010","journal-title":"Journal of immunology (Baltimore, Md. : 1950)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0140","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-015-0490-8","article-title":"CD8 T cells and Mycobacterium tuberculosis infection","volume":"37","author":"Lin","year":"2015","journal-title":"Seminars in immunopathology"},{"key":"10.1016\/j.molimm.2019.10.023_bib0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.molimm.2019.10.023_bib0150","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN-gamma-independent immune markers of Mycobacterium tuberculosis exposure","volume":"25","author":"Lu","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.molimm.2019.10.023_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075684","article-title":"ESAT-6 and HspX improve the effectiveness of BCG to induce human dendritic cells-dependent Th1 and NK cells activation","volume":"8","author":"Marongiu","year":"2013","journal-title":"PloS one"},{"key":"10.1016\/j.molimm.2019.10.023_bib0160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1099\/00221287-147-2-459","article-title":"Differential expression of mycobacterial proteins following phagocytosis by macrophages","volume":"147","author":"Monahan","year":"2001","journal-title":"Microbiology (Reading, England)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0165","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4049\/jimmunol.1601340","article-title":"T cell-derived IL-10 impairs host resistance to Mycobacterium tuberculosis infection","volume":"199","author":"Moreira-Teixeira","year":"2017","journal-title":"J Immunol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0170","doi-asserted-by":"crossref","first-page":"17286","DOI":"10.1038\/s41598-017-17587-5","article-title":"Boosting with recombinant MVA expressing M. tuberculosis alpha-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs","volume":"7","author":"Nangpal","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2019.10.023_bib0175","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1038\/s41598-017-02003-9","article-title":"Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis","volume":"7","author":"Nascimento","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.molimm.2019.10.023_bib0180","first-page":"702","article-title":"Changes in avidity and level of immunoglobulin G antibodies to <em>Mycobacterium tuberculosis<\/em> in sera of patients undergoing treatment for pulmonary tuberculosis","volume":"10","author":"Pereira Arias-Bouda","year":"2003","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00430-012-0278-6","article-title":"Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines","volume":"202","author":"Prabowo","year":"2013","journal-title":"Med. Microbiol. Immunol. (Berl)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0190","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during M. tuberculosis infection","volume":"4","author":"Redford","year":"2011","journal-title":"Mucosal immunology"},{"key":"10.1016\/j.molimm.2019.10.023_bib0195","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bjid.2012.10.009","article-title":"Challenges in the development of drugs for the treatment of tuberculosis","volume":"17","author":"Shehzad","year":"2013","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.molimm.2019.10.023_bib0200","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1016\/j.vaccine.2010.05.063","article-title":"Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein","volume":"28","author":"Shi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2019.10.023_bib0205","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/emm.2005.17","article-title":"Common interleukin 10 polymorphism associated with decreased risk of tuberculosis","volume":"37","author":"Shin","year":"2005","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.molimm.2019.10.023_bib0210","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0022-2018","article-title":"Immunology of Mycobacterium tuberculosis infections","volume":"7","author":"Sia","year":"2019","journal-title":"Microbiol. Spect."},{"key":"10.1016\/j.molimm.2019.10.023_bib0215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/1040841X.2011.606425","article-title":"Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: scope in diagnosis, vaccine design and therapy","volume":"37","author":"Siddiqui","year":"2011","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0220","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/icb.2012.34","article-title":"HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule","volume":"90","author":"Taylor","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2017.10.014","article-title":"Evaluation of profile and functionality of memory T cells in pulmonary tuberculosis","volume":"192","author":"Tonaco","year":"2017","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2019.10.023_bib0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12979-015-0033-0","article-title":"The combined molecular adjuvant CASAC enhances the CD8+ T cell response to a tumor-associated self-antigen in aged, immunosenescent mice","volume":"12","author":"Tye","year":"2015","journal-title":"Immunity & ageing: I & A"},{"key":"10.1016\/j.molimm.2019.10.023_bib0235","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-3083.1997.d01-432.x","article-title":"Induction of CD8+ CTL recognizing mycobacterial peptides","volume":"45","author":"Vordermeier","year":"1997","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2019.10.023_bib0240","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.4049\/jimmunol.181.5.3422","article-title":"Combined triggering of dendritic cell receptors results in synergistic activation and potent cytotoxic immunity","volume":"181","author":"Wells","year":"2008","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"10.1016\/j.molimm.2019.10.023_bib0245","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11515-018-1494-2","article-title":"HspX protein as a candidate vaccine against Mycobacterium tuberculosis: an overview","volume":"13","author":"Yousefi-Avarvand","year":"2018","journal-title":"Frontiers in Biology"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019301762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589019301762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:33:24Z","timestamp":1758980004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589019301762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":49,"alternative-id":["S0161589019301762"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2019.10.023","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC)","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2019.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}